Galaxy Emergency Hospital & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 28-05-2024
- Paid Up Capital ₹ 1.75 M
as on 28-05-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 13.99%
(FY 2019)
- Profit 56.32%
(FY 2019)
- Ebitda 6.27%
(FY 2019)
- Net Worth 345.04%
(FY 2019)
- Total Assets 1.79%
(FY 2019)
About Galaxy Emergency Hospital & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.75 M, as per Ministry of Corporate Affairs (MCA) records.
Anirudh Kumar, Brajesh Singh, Dipika Suman, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100BR2015PTC024079
- Company No.
024079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Galaxy Emergency Hospital & Research Centre?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Kumar  | Director | 02-Feb-2022 | Current |
| Brajesh Singh | Director | 02-Feb-2022 | Current |
| Dipika Suman | Additional Director | 03-May-2018 | Current |
| Pankaj Singh | Director | 04-Apr-2018 | Current |
| Ramesh Bharti | Director | 17-Apr-2015 | Current |
Financial Performance of Galaxy Emergency Hospital & Research Centre.
Galaxy Emergency Hospital & Research Centre Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 13.99% increase. The company also saw a substantial improvement in profitability, with a 56.32% increase in profit. The company's net worth Soared by an impressive increase of 345.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galaxy Emergency Hospital & Research Centre?
In 2017, Galaxy Emergency Hospital & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Galaxy Emergency Hospital & Research Centre?
Unlock and access historical data on people associated with Galaxy Emergency Hospital & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galaxy Emergency Hospital & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy Emergency Hospital & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
